复方蒿甲醚(Coartem)是周义清和宁殿玺教授等老一辈军事医学科学家近30年的原创发明专利药品，在瑞士诺华公司的鼎力和全心努力下已经成为全球抗击疟疾...
基于526个网页-相关网页
复方蒿甲醚及其组分单药治疗恶性疟的临床研究-临床医学论文-论文联盟 关键词】 复方蒿甲醚；蒿甲醚；本芴醇；恶性疟 [gap=837]Key words】 co-artemether；artemether；benflumetol；falciparum malaria
基于144个网页-相关网页
复方蒿甲醚片 Compound Artemether Tablets ; Artemether Compound Tablets
目前已有80多个国家批准了复方蒿甲醚的注册。
方法采用双盲随机对比法，共收治恶性疟患者151例，其中蒿甲醚为50例，本芴醇为51例，复方蒿甲醚为50例。
Methods Of 151 patients, 50 patients were treated with artemether , 51 patients were treated with benflumetol and 50 patients were treated with combined regime(co-artemether).
他们用青蒿素的一种衍生物——蒿甲醚代替青蒿素，协助改进了固定复方药。
They helped improve the fixed combination by replacing artemisinin with [one of its derivatives], artemether.
应用推荐